Mini drug pump for ophthalmic use

Current Eye Research

Volumn 35, Issue 3, 2010, Pages 192-201

  Saati, Saloomeh ^a   Lo, Ronalee ^b   Li, Po Ying ^b   Meng, Ellis ^b   Varma, Rohit ^a   Humayun, Mark S ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b University of Southern California   (United States)

Author keywords

Drug delivery; Ocular; Pump; Rabbit eye; Refilling

Indexed keywords

TRYPAN BLUE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CANNULA; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRAIN; DRUG DELIVERY SYSTEM; ELECTROLYSIS; FEASIBILITY STUDY; FLUORESCENCE ANGIOGRAPHY; IMPLANTATION; MICROELECTROMECHANICAL SYSTEM; NONHUMAN; PHOTOGRAPHY; PRIORITY JOURNAL; SLIT LAMP;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; FLUORESCEIN ANGIOGRAPHY; INFUSION PUMPS, IMPLANTABLE; MATERIALS TESTING; MYDRIATICS; PHENYLEPHRINE; PUPIL; RABBITS; TRYPAN BLUE;

EID: 77950811712     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903521936     Document Type: Article

References (37)

1. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 2000;41:961-964 (Pubitemid 30187528)
2. Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: A review. Drugs 2000;59:411-434
3. Hsu J. Drug delivery methods for posterior segment disease. Curr Opin Ophthalmol 2007;18:235-239 (Pubitemid 46624923)
4. Shell JW. Ophthalmic drug delivery systems. Surv Ophthalmol 1984;29:117-128
5. Davies NM. Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharmacol Physiol 2000;27:558-562 (Pubitemid 30418006)
6. Sultana Y, Jain R, Aqil M, et al. Review of ocular drug delivery. Curr Drug Deliv 2006;3:207-217 (Pubitemid 43725018)
7. Bourlais CL, Acar L, Zia H, et al. Ophthalmic drug delivery systems-Recent advances. Prog Retin Eye Res 1998;17:33-58 (Pubitemid 28040752)
8. Metrikin DC, Anand R. Intravitreal drug administration with depot devices. Curr Opin Ophthamol 1994;5:21-29 (Pubitemid 24172442)
9. Ho QT, Kuo CJ. Vascular endothelial growth factor: Biology and therapeutic applications. Int J Biochem Cell Bio 2007;39:1349-1357 (Pubitemid 47031045)
10. Lloyd R, Harris J, Wadhwa S, et al. Food and Drug Administration approval process for ophthalmic drugs in the US. Curr Opin Ophthalmol 2008;19:190-194 (Pubitemid 351535913)
11. Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 2005;40:63-68 (Pubitemid 40470519)
12. Li P-Y, Shih J, Lo R, et al. An electrochemical intraocular drug delivery device. Sensors and Actuators A: Physical 2008;143:41-48 (Pubitemid 351417358)
13. Lo R, Li P-Y, Agrawal RN, et al. A passive refillable intraocular MEMS drug delivery device. Lab on a Chip 2008;8:1027-1030
14. Agrawal RN, He S, Spee C, et al. In vivo models of proliferative vitreoretinopathy. Nat Protoc 2007;2:67-77 (Pubitemid 47040070)
15. Lattanzio FA, Jr., Sheppard JD, Jr., Allen RC, et al. Do injections of 5-fluorouracil after trabeculectomy have toxic effects on the anterior segment? J Ocul Pharmacol Ther 2005;21:223-235
16. Lad EM, Moshfeghi DM. Minimizing the risk of endophthalmitis following intravitreal injections. Compr Ophthalmol Update 2006;7:277-284; discussion 285-1276 (Pubitemid 46579460)
17. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695 e1-e15 (Pubitemid 44442453)
18. Bashshur ZF, Bazarbachi A, Schakal A, et al. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006;142:1-9 (Pubitemid 43946791)
19. Costa RA, Jorge R, Calucci D, et al. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 2007;27:141-149 (Pubitemid 46245639)
20. Dash AK, Cudworth GC, 2nd. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 1998;40:1-12 (Pubitemid 29062900)
21. Ambati J, Gragoudas ES, Miller JW, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci 2000;41:1186-1191 (Pubitemid 30187559)
22. Berg AVD, Lammerink TSJ. Micro total analysis systems: Microfluidic aspects, integration concept and applications. Microcys Technol Chem Life Sci Topic Curr Chem 1998;194:21-49
23. Shoji S. Fluids for sensor systems. Topics Curr Chem 1998;194:163-188
24. Vilkner T, Janasek D, Manz A.Micro total analysis systems. Recent developments. Analyt Chem 2004;76:3373-3385 (Pubitemid 38747275)
25. Razzacki SZ, Thwar PK, Yang M, et al. Integrated microsystems for controlled drug delivery. Adv Drug Deliv Rev 2004;56:185-198 (Pubitemid 38114930)
26. Richards Grayson AC, Scheidt Shawgo R, Li Y, et al. Electronic MEMS for triggered delivery. Adv Drug Deliv Rev 2004;56:173-184 (Pubitemid 38114929)
27. Rodger DC, Wieland JD, Humayun MS, et al. Scalable high lead-count parylene package for retinal prostheses. Sensors and Actuators B: Chemical 2006;117:107-114
28. Wu HK, Huang B, Zare RN. Construction of microfluidic chips using polydimethylsiloxane for adhesive bonding. Lab on a Chip 2005;5:1393-1398 (Pubitemid 41785264)
29. Phillip M, Battelino T, Rodriguez H, et al. Use of insulin pump therapy in the pediatric age-group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007;30:1653-1662 (Pubitemid 46871195)
30. Ronn B, Mathiesen ER, Vang L, et al. Evaluation of insulin pump treatment under routine conditions. Diabetes Res Clin Pract 1987;3:191-196 (Pubitemid 17092552)
31. Kim CS, Yim JH, Lee EK, et al. Changes in corneal endothelial cell density and morphology after Ahmed glaucoma valve implantation during the first year of follow up. Clin Experiment Ophthalmol 2008;36:142-147
32. Lim KS. Corneal endothelial cell damage from glaucoma drainage device materials. Cornea 2003;22:352-354
33. van Dooren BT, Beekhuis WH, Pels E. Biocompatibility of trypan blue with human corneal cells. Arch Ophthalmol 2004;122:736-742 (Pubitemid 38596254)
34. Gloor B, Gloor ML, Merz-Hill M, et al. Wound healing of the corneal posterior surface in animal experiments. Klin Monatsbl Augenheilkd 1986;188:225-230 (Pubitemid 16131334)
35. Ichijima H, Petroll WM, Jester JV, et al. In vivo confocal microscopic studies of endothelial wound healing in rabbit cornea. Cornea 1993;12:369-378 (Pubitemid 23249316)
36. Olsen EG, Davanger M. The healing of rabbit corneal endothelium. Acta Ophthalmol (Copenh) 1984;62:796-807 (Pubitemid 14006326)
37. Van Horn DL, Sendele DD, Seideman S, et al. Regenerative capacity of the corneal endothelium in rabbit and cat. Invest Ophthalmol Vis Sci 1977;16:597-613 (Pubitemid 8154279)